Beckman Coulter Diagnostics introduces a new integrated system of technologies and capabilities called DxONE, designed to ease data access and usability. DxONE was created in response to the increasing challenges faced by laboratory technicians to expedite result times, reduce costs, maneuver personnel shortages and navigate network consolidations.
The association of biofilms with multi-drug resistance has highlighted the need for further understanding of biofilms and for anti-biofilm strategies.
A new technique – single cell RNA-sequencing – may offer answers and hope to the 200,000 mothers and partners affected by pregnancy loss in the UK every year.
Genomic Health announced that the 15th St. Gallen International Breast Cancer Conference Expert Panel endorsed the use of genomic tests in early-stage breast cancer and recognised the Oncotype DX Breast Recurrence Score test for its prognostic ability as well as its value in guiding treatment decisions on adjuvant chemotherapy for patients with early-stage, endocrine sensitive, invasive breast…
A new test may help to identify breast cancer patients with the lowest risk of death, therefore helping them to avoid unnecessarily aggressive treatment.
Laboratories are an essential part of effective modern healthcare. They provide clinicians with vital information that helps them make life-saving decisions, diagnose conditions and monitor patient treatment.
Scientists in the UK have developed a new model that will help to advance the study of resistance to antibiotics.
While new agents to fight virulent pathogens are in the pipeline, a new study pinpoints where a recent addition is already being applied in the clinic.
'Blood is a very special juice’ – something even Goethe’s Mephistopheles knew. Medics have also known this for centuries, so it’s nothing new that the ‘juice’ and its properties receive a lot of attention in medicine. However, what is new is that dealing with the use of blood through patient blood management (PBM) is coming to the fore.
Since autumn 2016 a small tube has been making daily life easier for users and patients. A simple but effective addition now offers many new advantages in analysis, the manufacturer reports.
In our interview with the physician Dr. Fabian Berger, we want to know about the advantages of molecular biological procedures compared to conventional C. difficile diagnostics.
A new drive to increase the clinical effectiveness of laboratory medicine and take the discipline into a new era is being launched. Coupled with steps to harmonise laboratory medicine services across Europe, a move to make lab medicine more clinically effective is being spearheaded by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). The latest position were…
Improved harmonisation of laboratory medicine practice across Europe will help lead to better patient outcomes and produce comparable laboratory information irrespective of where and how the data have been generated.
Cancer biomarker testing represents an important element of the clinical biochemistry service, yet progress in this area in the last two decades has been slow.
People working in clinical laboratories often believe their work is of the highest quality, and adhere to what they believe is the highest standard – which is their personal opinion.
SpeeDx Pty, Ltd. announced an agreement with Cepheid for distribution of its PlexPCRTM and ResistancePlusTM molecular diagnostic products in key markets throughout Europe. The agreement, covering Germany, France, Italy, and the UK, will increase coverage for the market-leading ResistancePlus MG test, the first CE-IVD test for Mycoplasma genitalium to combine detection with testing for…
Oxford Gene Technology (OGT), The Molecular Genetics Company, today announced that it has signed an agreement to be acquired by Sysmex Corporation, a Japanese in vitro diagnostic company.
SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced the first and only FDA-cleared (via the de novo pathway) LC-MS based Vitamin D assay kit, the Vitamin D 200M Assay, exclusively for the SCIEX Topaz System. The Topaz System is a fully integrated LC-MS platform driven by ClearCore MD, the new and intuitive…
In order to enhance its hematology portfolio for the small-mid size laboratories segment, HORIBA Medical has developed a new hematology diagnostic solution. The new Yumizen H550 has been designed to meet the challenging laboratories requirements of providing a cost effective solution based on ‘state of art’ hematology diagnosis combined with user friendly operation.
The new Milli-Q IQ 7000 ultrapure water system is designed to make work in the lab easier and more efficient than ever. Its ergonomic design improves productivity; an HD digital touchscreen enables intuitive navigation and quick access to information; and ech2o mercury-free UV lamps are environmentally friendly.
Ideal for high-throughput, regular use, Olympus’ ergonomic CX43 and CX33 microscopes deliver superior comfort and reduce fatigue during long periods of routine microscopy.
Following a top level EU report showing antimicrobial resistance (AMR) remains high, Professor Mike Catchpole, Chief Scientist at the European Centre for Disease Prevention and Control (ECDC), has warned that stricter use of antibiotics is critical.
Globalisation has been a defining term in this 21st century: with almost anybody able to visit any place at any time, diseases, viruses and bacteria can be travel companions. Thus virology is gaining increased attention. Professor Barbara Gärtner, President of the German Association of Virology, talks about the issues and challenges arising from this development.
Medical laboratories must be pro-active if they are to meet the new challenges being presented to the sector globally, according to Dr William Morice from the renowned Mayo Clinic in America.
European Hospital reports a new approach in molecular diagnostics introduced during the IASLC World Conference in Vienna.